Moreover, low level of IDO increases the susceptibility of cervical cancer cells to NK cells, suggesting that IDO-targeted shRNAs may represent an effective molecular targeted therapy for cervical cancer [58] (Table 1). Here, IDO1 is linked to cervical cancer.